Role of thrombin in the pathogenesis of atherosclerosis

Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activa...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of cellular biochemistry Ročník 120; číslo 4; s. 4757 - 4765
Hlavní autori: Jaberi, Najmeh, Soleimani, Atena, Pashirzad, Mehran, Abdeahad, Hosein, Mohammadi, Fariba, Khoshakhlagh, Mahdieh, Khazaei, Majid, Ferns, Gordon A, Avan, Amir, Hassanian, Seyed Mahdi
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Wiley Subscription Services, Inc 01.04.2019
Predmet:
Aorta
Arteriosclerosis
Atherosclerosis
Cardiovascular diseases
Cardiovascular system
Cell adhesion
Cell adhesion & migration
Cell adhesion molecules
Cell proliferation
Cytokines
Heart diseases
inflammation
Inhibitor drugs
Inhibitors
Lesions
Muscles
Pathogenesis
Pharmacology
Plaques
Serine
Serine proteinase
Smooth muscle
Thrombin
thrombin inhibitors
atherosclerosis
thrombin
inflammation
thrombin inhibitors
ISSN:0730-2312, 1097-4644, 1097-4644
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.
AbstractList Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.
Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.
Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.
Author Soleimani, Atena
Abdeahad, Hosein
Mohammadi, Fariba
Khazaei, Majid
Pashirzad, Mehran
Ferns, Gordon A
Avan, Amir
Khoshakhlagh, Mahdieh
Jaberi, Najmeh
Hassanian, Seyed Mahdi
Author_xml – sequence: 1
  givenname: Najmeh
  surname: Jaberi
  fullname: Jaberi, Najmeh
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 2
  givenname: Atena
  surname: Soleimani
  fullname: Soleimani, Atena
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 3
  givenname: Mehran
  surname: Pashirzad
  fullname: Pashirzad, Mehran
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 4
  givenname: Hosein
  surname: Abdeahad
  fullname: Abdeahad, Hosein
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 5
  givenname: Fariba
  surname: Mohammadi
  fullname: Mohammadi, Fariba
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 6
  givenname: Mahdieh
  surname: Khoshakhlagh
  fullname: Khoshakhlagh, Mahdieh
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 7
  givenname: Majid
  surname: Khazaei
  fullname: Khazaei, Majid
  organization: Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 8
  givenname: Gordon A
  surname: Ferns
  fullname: Ferns, Gordon A
  organization: Brighton and Sussex Medical School
– sequence: 9
  givenname: Amir
  orcidid: 0000-0002-4968-0962
  surname: Avan
  fullname: Avan, Amir
  organization: School of Medicine, Mashhad University of Medical Sciences
– sequence: 10
  givenname: Seyed Mahdi
  orcidid: 0000-0002-5247-4043
  surname: Hassanian
  fullname: Hassanian, Seyed Mahdi
  email: hasanianmehrm@mums.ac.ir
  organization: Metabolic Syndrome Research Center, Mashhad University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30269382$$D View this record in MEDLINE/PubMed
BookMark eNp1kF9LwzAUxYNM3KY--AVk4Is-dEvStGkedfiXgSD6HNL01mW0zUxaZN_e1G0vQyEkhPs7h3PPGA0a2wBCFwRPCcZ0ttL5lHLOyREaESx4xFLGBmiEeYwjGhM6RGPvVxhjIWJ6goYxpqmIMzpC_M1WMLHlpF06W-emmYTTLmGyVu3SfkID3vh-Hr7grNdVfxt_ho5LVXk4372n6OPh_n3-FC1eH5_nt4tIMyJIBIBVlvGkzLKEaEGgFHmSl5qzlBYpIZDyDFKiBMOswMAZK8K8zx1iFynEp-h667t29qsD38raeA1VpRqwnZeUkCTsQjIR0KsDdGU714R0gcriUBRPe-pyR3V5DYVcO1Mrt5H7SgIw2wI6LOodlFKbVrXGNq1TppIEy750GUqXv6UHxc2BYm_6F7tz_zYVbP4H5cv8bqv4AboWjb8
CitedBy_id crossref_primary_10_3390_ijms23158134
crossref_primary_10_52727_2078_256X_2025_21_1_60_91
crossref_primary_10_1016_j_lwt_2024_116876
crossref_primary_10_3390_ijms25105228
crossref_primary_10_1016_j_blre_2020_100694
crossref_primary_10_1039_D5TB00487J
crossref_primary_10_1021_acsbiomaterials_5c00222
crossref_primary_10_3390_ijms23105845
crossref_primary_10_2147_JIR_S294809
crossref_primary_10_2174_1381612828666220518095025
crossref_primary_10_1016_j_foodchem_2023_137183
crossref_primary_10_1016_j_microc_2024_112147
crossref_primary_10_18087_cardio_2022_3_n1968
crossref_primary_10_1249_MSS_0000000000002846
crossref_primary_10_1002_cplu_202200325
crossref_primary_10_1186_s12872_023_03211_0
crossref_primary_10_1016_j_bioelechem_2023_108635
crossref_primary_10_3390_metabo15040224
crossref_primary_10_3390_mi13091441
crossref_primary_10_1002_pca_3447
crossref_primary_10_3390_cells12091222
crossref_primary_10_1002_ddr_21773
crossref_primary_10_3389_fnins_2020_00762
crossref_primary_10_1039_D2RA06891E
crossref_primary_10_1093_cvr_cvaf112
crossref_primary_10_1155_2021_1498431
crossref_primary_10_1055_s_0041_1727116
crossref_primary_10_1155_2022_5799308
crossref_primary_10_1161_ATVBAHA_120_314560
crossref_primary_10_1161_ATVBAHA_120_314147
crossref_primary_10_3390_foods9070854
crossref_primary_10_3390_cells11101718
Cites_doi 10.1111/j.1538-7836.2005.01377.x
10.1016/S0031-6997(24)01493-5
10.1160/TH10-06-0384
10.1016/j.jacc.2009.03.044
10.1097/00062752-200701000-00011
10.1182/blood.V87.4.1238.bloodjournal8741238
10.1093/cvr/cvr220
10.1161/01.ATV.18.12.1861
10.1055/s-2007-999001
10.1016/S0022-2275(20)38480-7
10.1182/blood-2007-04-086611
10.1160/th15-07-0598
10.1007/s40268-016-0158-4
10.1182/blood-2007-02-075440
10.1161/JAHA.114.001505
10.1161/01.CIR.98.21.2301
10.1016/0002-9149(95)80019-O
10.1160/TH07-08-0481
10.1161/01.CIR.94.1.88
10.1016/0002-8703(80)90352-X
10.4049/jimmunol.162.9.5466
10.1172/JCI109220
10.1161/ATVBAHA.107.161240
10.1016/0092-8674(91)90261-V
10.1055/s-2007-1002425
10.1016/j.bbrc.2011.07.031
10.1182/blood-2005-09-3780
10.1038/jcbfm.2009.283
10.1172/JCI116206
10.4049/jimmunol.169.3.1467
10.1074/jbc.M008160200
10.1172/JCI27095
10.1016/j.jacc.2014.07.997
10.1038/35025229
10.1055/s-0037-1616227
10.1038/19546
10.1046/j.1365-2567.1996.d01-635.x
10.1161/01.ATV.20.4.1143
10.1161/ATVBAHA.115.306973
10.1016/j.thromres.2008.04.019
10.1074/jbc.M302137200
10.1161/01.RES.77.3.503
10.1023/A:1026144518686
10.1111/j.1749-6632.1997.tb52024.x
10.1146/annurev.iy.12.040194.001041
10.1161/01.RES.0000033520.95242.A2
10.1084/jem.191.3.455
10.1084/jem.20071427
10.1161/01.CIR.0000129968.46095.F3
10.1160/TH05-06-0415
10.1016/j.bbrc.2010.05.009
10.1016/0014-5793(95)00552-K
10.1056/NEJMoa1200933
10.1161/01.ATV.0000256471.22437.88
10.1161/ATVBAHA.115.306697
10.1007/s11010-011-1024-x
10.1093/cvr/cvp066
10.1007/s11239-013-1026-5
10.1016/j.thromres.2005.03.017
10.1016/j.thromres.2012.02.028
10.1074/jbc.M001659200
10.1073/pnas.95.12.6642
10.1016/S0021-9258(18)94073-1
10.1038/35092573
10.1083/jcb.119.4.935
10.1002/jcp.25753
10.1161/01.CIR.84.1.232
10.1002/jcp.24568
10.1152/jappl.1989.66.3.1471
10.1056/NEJM199901143400207
10.1083/jcb.101.3.880
10.1161/01.CIR.0000024982.11646.25
10.1002/jcp.25501
ContentType Journal Article
Copyright 2018 Wiley Periodicals, Inc.
2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2018 Wiley Periodicals, Inc.
– notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
NPM
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1002/jcb.27771
DatabaseName CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Virology and AIDS Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed
Virology and AIDS Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1097-4644
EndPage 4765
ExternalDocumentID 30269382
10_1002_jcb_27771
JCB27771
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Mashhad University of Medical Sciences
  funderid: 940937; 940938
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH6
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V8K
W8V
W99
WBKPD
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WSB
WXSBR
WYISQ
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
NPM
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c4191-ee0a8875f8851c91ef9b5bfc7462d611e678e61a9404d0e744db5b0730231d6e3
IEDL.DBID DRFUL
ISICitedReferencesCount 43
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000459010100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0730-2312
1097-4644
IngestDate Fri Jul 11 15:10:46 EDT 2025
Sat Nov 29 14:36:06 EST 2025
Wed Feb 19 02:31:34 EST 2025
Sat Nov 29 07:06:21 EST 2025
Tue Nov 18 22:20:14 EST 2025
Wed Jan 22 16:40:33 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords atherosclerosis
thrombin
inflammation
thrombin inhibitors
Language English
License 2018 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4191-ee0a8875f8851c91ef9b5bfc7462d611e678e61a9404d0e744db5b0730231d6e3
Notes Najmeh Jaberi, Atena Soleimani, Mehran Pashirzad, Hosein Abdeahad, Fariba Mohammadi, and Mahdieh Khoshakhlagh have contributed equally to this study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4968-0962
0000-0002-5247-4043
PMID 30269382
PQID 2183002769
PQPubID 1006368
PageCount 9
ParticipantIDs proquest_miscellaneous_2115269189
proquest_journals_2183002769
pubmed_primary_30269382
crossref_citationtrail_10_1002_jcb_27771
crossref_primary_10_1002_jcb_27771
wiley_primary_10_1002_jcb_27771_JCB27771
PublicationCentury 2000
PublicationDate April 2019
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: April 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular biochemistry
PublicationTitleAlternate J Cell Biochem
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_9_1_36_1
e_1_2_9_1_13_1
e_1_2_9_1_34_1
e_1_2_9_1_11_1
e_1_2_9_1_32_1
Pingel S (e_1_2_9_1_75_1) 2014
e_1_2_9_1_30_1
Renaud S (e_1_2_9_1_58_1) 1979; 8
e_1_2_9_1_4_1
e_1_2_9_1_6_1
e_1_2_9_1_60_1
Spronk HM (e_1_2_9_1_77_1) 2012; 120
e_1_2_9_1_81_1
Macfarlane SR (e_1_2_9_1_15_1) 2001; 53
e_1_2_9_1_62_1
e_1_2_9_1_83_1
Alessandri C (e_1_2_9_1_57_1) 1996; 26
e_1_2_9_1_64_1
e_1_2_9_1_66_1
e_1_2_9_1_29_1
e_1_2_9_1_68_1
e_1_2_9_1_27_1
e_1_2_9_1_25_1
e_1_2_9_1_48_1
e_1_2_9_1_23_1
e_1_2_9_1_46_1
Narayanan S (e_1_2_9_1_2_1) 1999; 29
e_1_2_9_1_21_1
e_1_2_9_1_44_1
e_1_2_9_1_42_1
e_1_2_9_1_40_1
e_1_2_9_1_8_1
e_1_2_9_1_50_1
e_1_2_9_1_73_1
e_1_2_9_1_52_1
e_1_2_9_1_54_1
e_1_2_9_1_18_1
e_1_2_9_1_56_1
e_1_2_9_1_79_1
e_1_2_9_1_16_1
e_1_2_9_1_39_1
e_1_2_9_1_14_1
e_1_2_9_1_37_1
e_1_2_9_1_12_1
e_1_2_9_1_35_1
e_1_2_9_1_10_1
e_1_2_9_1_33_1
e_1_2_9_1_31_1
e_1_2_9_1_3_1
e_1_2_9_1_5_1
e_1_2_9_1_80_1
e_1_2_9_1_82_1
e_1_2_9_1_61_1
e_1_2_9_1_63_1
e_1_2_9_1_65_1
e_1_2_9_1_67_1
e_1_2_9_1_69_1
e_1_2_9_1_28_1
e_1_2_9_1_49_1
e_1_2_9_1_26_1
e_1_2_9_1_47_1
Borissoff JI (e_1_2_9_1_76_1) 2010; 122
e_1_2_9_1_24_1
e_1_2_9_1_45_1
e_1_2_9_1_22_1
e_1_2_9_1_43_1
e_1_2_9_1_20_1
e_1_2_9_1_41_1
Barry WL (e_1_2_9_1_71_1) 1997; 77
e_1_2_9_1_7_1
e_1_2_9_1_9_1
e_1_2_9_1_70_1
e_1_2_9_1_51_1
e_1_2_9_1_72_1
e_1_2_9_1_53_1
e_1_2_9_1_74_1
e_1_2_9_1_55_1
e_1_2_9_1_19_1
e_1_2_9_1_78_1
e_1_2_9_1_17_1
e_1_2_9_1_38_1
e_1_2_9_1_59_1
References_xml – ident: e_1_2_9_1_13_1
  doi: 10.1111/j.1538-7836.2005.01377.x
– volume: 53
  start-page: 245
  year: 2001
  ident: e_1_2_9_1_15_1
  article-title: Proteinase‐activated receptors
  publication-title: Pharmacol Rev
  doi: 10.1016/S0031-6997(24)01493-5
– ident: e_1_2_9_1_66_1
  doi: 10.1160/TH10-06-0384
– ident: e_1_2_9_1_19_1
  doi: 10.1016/j.jacc.2009.03.044
– ident: e_1_2_9_1_40_1
  doi: 10.1097/00062752-200701000-00011
– ident: e_1_2_9_1_28_1
  doi: 10.1182/blood.V87.4.1238.bloodjournal8741238
– ident: e_1_2_9_1_60_1
  doi: 10.1093/cvr/cvr220
– ident: e_1_2_9_1_62_1
  doi: 10.1161/01.ATV.18.12.1861
– ident: e_1_2_9_1_51_1
  doi: 10.1055/s-2007-999001
– ident: e_1_2_9_1_52_1
  doi: 10.1016/S0022-2275(20)38480-7
– ident: e_1_2_9_1_69_1
  doi: 10.1182/blood-2007-04-086611
– ident: e_1_2_9_1_48_1
  doi: 10.1160/th15-07-0598
– ident: e_1_2_9_1_83_1
  doi: 10.1007/s40268-016-0158-4
– ident: e_1_2_9_1_10_1
  doi: 10.1182/blood-2007-02-075440
– ident: e_1_2_9_1_80_1
  doi: 10.1161/JAHA.114.001505
– ident: e_1_2_9_1_73_1
  doi: 10.1161/01.CIR.98.21.2301
– ident: e_1_2_9_1_22_1
  doi: 10.1016/0002-9149(95)80019-O
– ident: e_1_2_9_1_42_1
  doi: 10.1160/TH07-08-0481
– ident: e_1_2_9_1_72_1
  doi: 10.1161/01.CIR.94.1.88
– ident: e_1_2_9_1_65_1
  doi: 10.1016/0002-8703(80)90352-X
– ident: e_1_2_9_1_9_1
  doi: 10.4049/jimmunol.162.9.5466
– ident: e_1_2_9_1_7_1
  doi: 10.1172/JCI109220
– ident: e_1_2_9_1_44_1
  doi: 10.1161/ATVBAHA.107.161240
– ident: e_1_2_9_1_23_1
  doi: 10.1016/0092-8674(91)90261-V
– ident: e_1_2_9_1_5_1
  doi: 10.1055/s-2007-1002425
– ident: e_1_2_9_1_47_1
  doi: 10.1016/j.bbrc.2011.07.031
– ident: e_1_2_9_1_55_1
  doi: 10.1182/blood-2005-09-3780
– ident: e_1_2_9_1_36_1
  doi: 10.1038/jcbfm.2009.283
– ident: e_1_2_9_1_21_1
  doi: 10.1172/JCI116206
– ident: e_1_2_9_1_34_1
  doi: 10.4049/jimmunol.169.3.1467
– ident: e_1_2_9_1_26_1
  doi: 10.1074/jbc.M008160200
– volume: 122
  start-page: 351
  year: 2010
  ident: e_1_2_9_1_76_1
  article-title: Direct thrombin inhibition by dabigatran protects against severe atherosclerosis progression in prothrombotic mice
  publication-title: Am Heart Assoc
– ident: e_1_2_9_1_64_1
  doi: 10.1172/JCI27095
– ident: e_1_2_9_1_81_1
  doi: 10.1016/j.jacc.2014.07.997
– ident: e_1_2_9_1_12_1
  doi: 10.1038/35025229
– ident: e_1_2_9_1_14_1
  doi: 10.1055/s-0037-1616227
– volume: 120
  start-page: 103
  year: 2012
  ident: e_1_2_9_1_77_1
  article-title: Thrombin inhibition prevents against severe atherosclerosis progression in prothrombotic mice
  publication-title: Am Soc Hematol
– ident: e_1_2_9_1_43_1
  doi: 10.1038/19546
– volume: 26
  start-page: 214
  year: 1996
  ident: e_1_2_9_1_57_1
  article-title: Relationship between prothrombin activation fragment F1 + 2 and serum cholesterol
  publication-title: Haemostasis
– volume: 77
  start-page: 109
  year: 1997
  ident: e_1_2_9_1_71_1
  article-title: A new single‐injury model of balloon angioplasty in cholesterol‐fed rabbits: beneficial effect of hirudin and comparison with double‐injury model
  publication-title: Lab Invest
– ident: e_1_2_9_1_45_1
  doi: 10.1046/j.1365-2567.1996.d01-635.x
– ident: e_1_2_9_1_49_1
  doi: 10.1161/01.ATV.20.4.1143
– ident: e_1_2_9_1_53_1
  doi: 10.1161/ATVBAHA.115.306973
– ident: e_1_2_9_1_54_1
  doi: 10.1016/j.thromres.2008.04.019
– ident: e_1_2_9_1_35_1
  doi: 10.1074/jbc.M302137200
– ident: e_1_2_9_1_46_1
  doi: 10.1161/01.RES.77.3.503
– ident: e_1_2_9_1_74_1
  doi: 10.1023/A:1026144518686
– ident: e_1_2_9_1_50_1
  doi: 10.1111/j.1749-6632.1997.tb52024.x
– ident: e_1_2_9_1_8_1
  doi: 10.1146/annurev.iy.12.040194.001041
– ident: e_1_2_9_1_30_1
  doi: 10.1161/01.RES.0000033520.95242.A2
– ident: e_1_2_9_1_32_1
  doi: 10.1084/jem.191.3.455
– ident: e_1_2_9_1_31_1
  doi: 10.1084/jem.20071427
– ident: e_1_2_9_1_63_1
  doi: 10.1161/01.CIR.0000129968.46095.F3
– ident: e_1_2_9_1_61_1
  doi: 10.1160/TH05-06-0415
– ident: e_1_2_9_1_41_1
  doi: 10.1016/j.bbrc.2010.05.009
– ident: e_1_2_9_1_3_1
  doi: 10.1016/0014-5793(95)00552-K
– ident: e_1_2_9_1_82_1
  doi: 10.1056/NEJMoa1200933
– ident: e_1_2_9_1_68_1
  doi: 10.1161/01.ATV.0000256471.22437.88
– ident: e_1_2_9_1_78_1
  doi: 10.1161/ATVBAHA.115.306697
– volume: 8
  start-page: 234
  year: 1979
  ident: e_1_2_9_1_58_1
  article-title: Dietary fats and platelet functions in relation to atherosclerosis and coronary heart disease
  publication-title: Haemostasis
– ident: e_1_2_9_1_39_1
  doi: 10.1007/s11010-011-1024-x
– ident: e_1_2_9_1_29_1
  doi: 10.4049/jimmunol.162.9.5466
– ident: e_1_2_9_1_37_1
  doi: 10.1093/cvr/cvp066
– ident: e_1_2_9_1_38_1
  doi: 10.1007/s11239-013-1026-5
– ident: e_1_2_9_1_79_1
  doi: 10.1016/j.thromres.2005.03.017
– ident: e_1_2_9_1_18_1
  doi: 10.1016/j.thromres.2012.02.028
– ident: e_1_2_9_1_67_1
  doi: 10.1074/jbc.M001659200
– ident: e_1_2_9_1_11_1
  doi: 10.1073/pnas.95.12.6642
– ident: e_1_2_9_1_25_1
  doi: 10.1172/JCI109220
– ident: e_1_2_9_1_59_1
  doi: 10.1016/S0021-9258(18)94073-1
– ident: e_1_2_9_1_33_1
  doi: 10.1038/35092573
– ident: e_1_2_9_1_6_1
  doi: 10.1083/jcb.119.4.935
– ident: e_1_2_9_1_17_1
  doi: 10.1002/jcp.25753
– ident: e_1_2_9_1_70_1
  doi: 10.1161/01.CIR.84.1.232
– ident: e_1_2_9_1_4_1
  doi: 10.1002/jcp.24568
– ident: e_1_2_9_1_24_1
  doi: 10.1152/jappl.1989.66.3.1471
– volume: 29
  start-page: 275
  year: 1999
  ident: e_1_2_9_1_2_1
  article-title: Multifunctional roles of thrombin
  publication-title: Ann Clin Lab Sci
– ident: e_1_2_9_1_20_1
  doi: 10.1056/NEJM199901143400207
– ident: e_1_2_9_1_27_1
  doi: 10.1083/jcb.101.3.880
– ident: e_1_2_9_1_56_1
  doi: 10.1161/01.CIR.0000024982.11646.25
– start-page: 154
  volume-title: Arch Med Sci
  year: 2014
  ident: e_1_2_9_1_75_1
– ident: e_1_2_9_1_16_1
  doi: 10.1002/jcp.25501
SSID ssj0009932
Score 2.46624
SecondaryResourceType review_article
Snippet Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4757
SubjectTerms Aorta
Arteriosclerosis
Atherosclerosis
Cardiovascular diseases
Cardiovascular system
Cell adhesion
Cell adhesion & migration
Cell adhesion molecules
Cell proliferation
Cytokines
Heart diseases
inflammation
Inhibitor drugs
Inhibitors
Lesions
Muscles
Pathogenesis
Pharmacology
Plaques
Serine
Serine proteinase
Smooth muscle
Thrombin
thrombin inhibitors
Title Role of thrombin in the pathogenesis of atherosclerosis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.27771
https://www.ncbi.nlm.nih.gov/pubmed/30269382
https://www.proquest.com/docview/2183002769
https://www.proquest.com/docview/2115269189
Volume 120
WOSCitedRecordID wos000459010100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  customDbUrl:
  eissn: 1097-4644
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009932
  issn: 0730-2312
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rS-QwEB901-Pui697rS-q-MEvPds0zQM_6eoiIiKist9Km6THHt72sO7B_fc305eICoJQSiDTJp2ZZH5pm98A7EYsyB1zgZ8byX0eq9RXhgkfI4OyEQJ6XRHP357Liws1HuvLOTho98LU_BDdCzcaGdV8TQM8zcr9R9LQXyb7waSk_eN9hn4b96B_fDW6OX_k3NVVfjJyYh9hDGuJhQK23138NBw9w5hPIWsVc0ZL7-rtMiw2UNM7rH1jBebcdBU-1Mkn_63Cx2Gb6-0zyKviznlF7lHWhN-4WPbwQGjoUcLi4ifNh5OS6iu8WJR4PzxPyi9wMzq5Hp76TUoF33BcmfnOBSlOK3GuEGkZHbpcZ3FGdhLMijB0GLucCFPNA24DJzm3WE8aRAVa4aKv0JsWU_cdvIw7FVubmSyS3DjEHdJmeYAFy0Uo2AD2Ws0mpuEbp7QXd0nNlMwS1ElS6WQAO53on5pk4yWhjdY8STPOyoQAHq2shR7AdleNyqPPHunUFTOSCSmNeqhQ5ltt1q4VfC6hI0Wdraz3evPJ2fCoKqy9XXQdPiG-0vWPPhvQe7ifuU1YMH8fJuX9FszLsdpqnPY_GETqzQ
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB7EVfTF-1jPKj74UrdNs2kDvujq4rEuIiq-lW2Syopuxa6C_96ZXiIqCEIphUybdGaS-ZI23wDseMyJDTOOHSuf27wZ9OxAMWFjZAi0h4BeZsTztx2_2w3u7uTlCOyXe2FyfohqwY16RjZeUwenBenGJ2vog4r2mO_TBvIaRzdC_64dXbVvOp-kuzJLUEZebCOOYSWzkMMa1c1f49E3kPkVs2ZBpz39v-bOwFQBNq2D3DtmYcQM5mA8Tz_5PgcTrTLb2zz4V8mjsZLYorwJTzhdtvBAcGhRyuLknkbEfkrlGWJMUnwenvvpAty0j69bJ3aRVMFWHOdmtjFODweWZhwg1lLSNbGMmhFZSjAtXNdg9DLC7UnucO0Yn3ON5aRC1KAWxluE0UEyMMtgRdwETa0jFXk-VwaRh6-j2MELzYUrWB12S9WGqmAcp8QXj2HOlcxC1EmY6aQO25Xoc06z8ZPQWmmfsOhpaUgQj-bWQtZhqypG5dGHj97AJK8k41IidTdAmaXcrlUt-F5CegE1NjPf79WHZ63D7GLl76KbMHFyfdEJO6fd81WYRLQl899-1mB0-PJq1mFMvQ376ctG4bsfqSbt1Q
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS9xAFD7IrrcX77ZrrabFh75Ek8nsJAN9qauLtssiouJb2MycyBa7EbMK_nvPyU2kCoVCCANzkpmcuZxvksz3AewFwktRoOemJpSu7EYjNzJCuRQZIhsQoNcF8fzVIBwOo-trfTYD3-u9MCU_RPPCjUdGMV_zAMc7mx68sIb-Nsm-CEPeQN6WLCLTgvbRef9y8EK6qwuBMu7FLuEYUTMLeeKgufh1PPoLZL7GrEXQ6S__X3VXYKkCm86PsneswgxO1mCulJ98WoOFXq32tg7heXaLTpY6rJvwh5bLDh0EDh2WLM5ueEYc55xfIMYsp_vReZxvwGX_-KJ34laiCq6RtDZzEb0RTSzdNCKsZbSPqU66CbeUElb5PlL0QuWPtPSk9TCU0lI-u5A8aBUGm9CaZBP8CE4iMepam5gkCKVBQh6hTVKPElYqX4kOfKtdG5uKcZyFL27jkitZxOSTuPBJB742pnclzcZbRtt1-8TVSMtjhni8tla6A1-abHIef_gYTTB7YBufhdT9iGw-lO3alELPpXQQcWWL5nu_-Phn77BIbP276S7Mnx3148Hp8NcnWCSwpcu_frahNb1_wM8wax6n4_x-p-q6z0237VA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+thrombin+in+the+pathogenesis+of+atherosclerosis&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Jaberi%2C+Najmeh&rft.au=Soleimani%2C+Atena&rft.au=Pashirzad%2C+Mehran&rft.au=Abdeahad%2C+Hosein&rft.date=2019-04-01&rft.issn=0730-2312&rft.eissn=1097-4644&rft.volume=120&rft.issue=4&rft.spage=4757&rft.epage=4765&rft_id=info:doi/10.1002%2Fjcb.27771&rft.externalDBID=10.1002%252Fjcb.27771&rft.externalDocID=JCB27771
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon